JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area cell cycle atm atr'

Search results for: 'research area cell cycle atm atr'

A4118 Hesperadin

1 Citation

Target: Aurora Kinases

Summary: Aurora B kinase inhibitor

≥25.85 mg/mL
A3794 SB1317

Summary: CDK,JAK and FLT inhibitor

insoluble in H2O; ≥44.87 mg/mL
A4110 MLN8237 (Alisertib)

6 Citation

Summary: Aurora A Kinase inhibitor, Potent and selective

≥25.95 mg/mL
A4112 Barasertib (AZD1152-HQPA)

3 Citation

Target: Aurora Kinases

Summary: Aurora Kinase B inhibitor, Potent and selective

≥25.4 mg/mL
A4125 CYC116

Target: Aurora Kinases|FLT3|VEGFR

Summary: Potent Aurora A/B inhibitor

insoluble in EtOH; insoluble in H2O; ≥18.4 mg/mL
A4126 Aurora A Inhibitor I

Target: Aurora Kinases

Summary: Aurora A inhibitor

≥29.4 mg/mL
A1877 XAV-939

1 Citation

Target: TNKS

Summary: Tankyrase 1/2 inhibitor

insoluble in H2O; insoluble in EtOH; ≥15.62 mg/mL
A8182 3-Deazaneplanocin A (DZNep) hydrochloride

1 Citation

Target: EZH2

Summary: SAHH and EZH2 inhibitor

insoluble in EtOH; ≥14.94 mg/mL
A4529 JW 55

Summary: PARP domain inhibitor

insoluble in H2O; ≥19.25 mg/mL
A4171 EPZ005687

2 Citation

Target: EZH2

Summary: EZH2 inhibitor,potent and selective

insoluble in EtOH; insoluble in H2O; ≥3.86 mg/mL